Flores-Gonzalez, J.; Ramon-Luing, L.A.; Ocaña-Guzman, R.; Buendia-Roldan, I.; Islas-Muñoz, B.; Volkow-Fernández, P.; Chavez-Galan, L.
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients. Cancers 2022, 14, 412.
https://doi.org/10.3390/cancers14020412
AMA Style
Flores-Gonzalez J, Ramon-Luing LA, Ocaña-Guzman R, Buendia-Roldan I, Islas-Muñoz B, Volkow-Fernández P, Chavez-Galan L.
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients. Cancers. 2022; 14(2):412.
https://doi.org/10.3390/cancers14020412
Chicago/Turabian Style
Flores-Gonzalez, Julio, Lucero A. Ramon-Luing, Ranferi Ocaña-Guzman, Ivette Buendia-Roldan, Beda Islas-Muñoz, Patricia Volkow-Fernández, and Leslie Chavez-Galan.
2022. "Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients" Cancers 14, no. 2: 412.
https://doi.org/10.3390/cancers14020412
APA Style
Flores-Gonzalez, J., Ramon-Luing, L. A., Ocaña-Guzman, R., Buendia-Roldan, I., Islas-Muñoz, B., Volkow-Fernández, P., & Chavez-Galan, L.
(2022). Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients. Cancers, 14(2), 412.
https://doi.org/10.3390/cancers14020412